SE396387B - Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan - Google Patents
Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkanInfo
- Publication number
- SE396387B SE396387B SE7300461A SE7300461A SE396387B SE 396387 B SE396387 B SE 396387B SE 7300461 A SE7300461 A SE 7300461A SE 7300461 A SE7300461 A SE 7300461A SE 396387 B SE396387 B SE 396387B
- Authority
- SE
- Sweden
- Prior art keywords
- carboxychromonyloxy
- cyanphenoxy
- therapentic
- propanes
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB191272A GB1405253A (en) | 1972-01-14 | 1972-01-14 | 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes |
Publications (1)
Publication Number | Publication Date |
---|---|
SE396387B true SE396387B (sv) | 1977-09-19 |
Family
ID=9730211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7300461A SE396387B (sv) | 1972-01-14 | 1973-01-12 | Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan |
Country Status (19)
Country | Link |
---|---|
US (1) | US3899513A (xx) |
JP (1) | JPS5411310B2 (xx) |
AR (1) | AR194869A1 (xx) |
BE (1) | BE793969A (xx) |
BR (1) | BR7300291D0 (xx) |
CA (1) | CA1010883A (xx) |
CH (1) | CH585702A5 (xx) |
DE (1) | DE2301541A1 (xx) |
DK (1) | DK135349C (xx) |
ES (1) | ES410559A1 (xx) |
FR (1) | FR2181667B1 (xx) |
GB (1) | GB1405253A (xx) |
HU (1) | HU164946B (xx) |
IL (1) | IL41227A (xx) |
NL (1) | NL7300408A (xx) |
NO (1) | NO138564C (xx) |
SE (1) | SE396387B (xx) |
SU (1) | SU469247A3 (xx) |
ZA (1) | ZA7358B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567201A (en) * | 1981-11-25 | 1986-01-28 | Takeda Chemical Industries, Ltd. | Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof |
US5135940A (en) * | 1982-09-23 | 1992-08-04 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
US4661505A (en) * | 1982-11-03 | 1987-04-28 | Eli Lilly And Company | Leukotriene antagonists |
US4820867A (en) * | 1983-04-21 | 1989-04-11 | Merck Frosst Canada, Inc. | Phenoxypropoxy halophenylacetic acids as leukotriene antagonists |
ZA844519B (en) * | 1983-06-24 | 1985-02-27 | Hoffmann La Roche | Dihydrobenzopyran derivatives |
US5105017A (en) * | 1983-07-18 | 1992-04-14 | Eli Lilly And Company | Leukotriene antagonist intermediates |
US4874777A (en) * | 1987-04-10 | 1989-10-17 | Eli Lilly And Company | Leukotriene antagonists |
US4853398A (en) * | 1987-04-13 | 1989-08-01 | Eli Lilly And Company | Leukotriene antagonists and use thereas |
US5352690A (en) * | 1992-07-01 | 1994-10-04 | Eli Lilly And Company | 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
WO2005080320A1 (en) | 2004-02-13 | 2005-09-01 | Warner-Lambert Company Llc | Androgen receptor modulators |
EP1737813A1 (en) | 2004-04-13 | 2007-01-03 | Warner-Lambert Company LLC | Androgen modulators |
JP2007533726A (ja) | 2004-04-22 | 2007-11-22 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
BRPI0513020A (pt) | 2004-07-08 | 2008-04-22 | Warner Lambert Co | moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
GB1190194A (en) * | 1966-07-05 | 1970-04-29 | Fisons Pharmaceuticals Ltd | Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives |
GB1292601A (en) * | 1968-10-30 | 1972-10-11 | Fisons Pharmaceuticals Ltd | Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them |
GB1290174A (xx) * | 1969-05-20 | 1972-09-20 | Fisons Pharmaceuticals Ltd | |
US3823165A (en) * | 1969-10-28 | 1974-07-09 | Fisons Ltd | Pharmaceutically active compounds |
-
1972
- 1972-01-12 SU SU1873458A patent/SU469247A3/ru active
- 1972-01-14 GB GB191272A patent/GB1405253A/en not_active Expired
-
1973
- 1973-01-02 CA CA160,351A patent/CA1010883A/en not_active Expired
- 1973-01-02 US US320600A patent/US3899513A/en not_active Expired - Lifetime
- 1973-01-03 IL IL41227A patent/IL41227A/en unknown
- 1973-01-11 NL NL7300408A patent/NL7300408A/xx not_active Application Discontinuation
- 1973-01-11 FR FR7300929A patent/FR2181667B1/fr not_active Expired
- 1973-01-12 CH CH45073A patent/CH585702A5/xx not_active IP Right Cessation
- 1973-01-12 HU HUMI520A patent/HU164946B/hu unknown
- 1973-01-12 SE SE7300461A patent/SE396387B/xx unknown
- 1973-01-12 BE BE793969D patent/BE793969A/xx unknown
- 1973-01-12 ES ES410559A patent/ES410559A1/es not_active Expired
- 1973-01-12 BR BR73291A patent/BR7300291D0/pt unknown
- 1973-01-12 AR AR246100A patent/AR194869A1/es active
- 1973-01-12 DE DE2301541A patent/DE2301541A1/de active Pending
- 1973-01-12 NO NO144/73A patent/NO138564C/no unknown
- 1973-01-12 DK DK19473A patent/DK135349C/da active
- 1973-01-13 ZA ZA730058A patent/ZA7358B/xx unknown
- 1973-01-13 JP JP699473A patent/JPS5411310B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5411310B2 (xx) | 1979-05-14 |
DK135349B (da) | 1977-04-12 |
FR2181667B1 (xx) | 1976-09-03 |
GB1405253A (en) | 1975-09-10 |
HU164946B (xx) | 1974-05-28 |
IL41227A0 (en) | 1973-03-30 |
IL41227A (en) | 1976-08-31 |
JPS4878171A (xx) | 1973-10-20 |
CA1010883A (en) | 1977-05-24 |
BE793969A (fr) | 1973-05-02 |
NO138564B (no) | 1978-06-19 |
US3899513A (en) | 1975-08-12 |
DK135349C (da) | 1977-09-26 |
CH585702A5 (xx) | 1977-03-15 |
NL7300408A (xx) | 1973-07-17 |
BR7300291D0 (pt) | 1973-10-25 |
ES410559A1 (es) | 1976-05-01 |
ZA7358B (en) | 1973-10-31 |
FR2181667A1 (xx) | 1973-12-07 |
NO138564C (no) | 1978-09-27 |
AR194869A1 (es) | 1973-08-24 |
SU469247A3 (ru) | 1975-04-30 |
DE2301541A1 (de) | 1973-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE407579B (sv) | Forfarande for framstellning av n-fosfonometylglycin | |
FI56686B (fi) | Foerfarande foer framstaellning av 7-aminocefalosporansyraderivat med antibiotis verkan | |
NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
SE396387B (sv) | Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan | |
SE380522B (sv) | Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan | |
SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
FI55184B (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer | |
SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
SE414025B (sv) | Forfarande for framstellning av fototropa flerfokala glasogonglas | |
SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
SE402451B (sv) | Forfarande for framstellning av 14-desoxi-14-acetoximutilin | |
SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
FI54311C (fi) | Foerfarande foer framstaellning av pyrimidinobenso-oxazepiner -tiazepiner -diazepiner och -azepiner med inverkan pao centralnervsystemet | |
SE393111B (sv) | Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin | |
SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
SE397827B (sv) | Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan | |
SE389105B (sv) | Forfarande for framstellning av vissa angivna ketaziner | |
SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
SE393808B (sv) | Forfarande for framstellning av isomaltit | |
SE415355B (sv) | Forfarande for framstellning av fosfonotioureider | |
SE391717B (sv) | Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner | |
SE380795B (sv) | Forfarande for framstellning av tiokarbamider |